Pediatric allergy and respiratory disease (소아알레르기 및 호흡기학회지)

The Korean Academy of Pediatric Allergy and Respiratory Diseasse (대한소아알레르기호흡기학회)
권호 표지

Probiotics:Action Mechanisms and Clinical Effects

프로바이오틱스의 임상적 효과와 작용 기작

Kim, Nam-Joo;Ji, Geun-Eok
김남주;지근억

  • Published : 20050000
⟨ Previous Next ⟩

Abstract

The establishment of balanced intestinal microbial flora bears importance in maintaining the well-being of the human host. In this context, probiotics improving the intestinal microflora confer a beneficial effect on human health when ingested as live microorganisms. Bifidobacterium and Lactobacillus are mainly used as probiotics in the pharmaceuticals or functional foods. On review of the papers published in the scientific journals, prophylactic use of probiotics was promising in reducing both the incidence and severity of necrotizing enterocolitis in preterm neonates, alleviating rotavirus infection and preventing the atopy symptoms in children. The efficacy of the probiotics with respect to the inflammatory disease such as Crohn's disease and ulcerative colitis are being studied. Analysis of the various cytokines and immune markers are being conducted to understand the mechanism of action of the probiotics related to allergy and inflammation. More clinical studies are needed based on appropriate and well-conducted trials with known strains and doses since the efficacy varies depending on the specific probiotic strains or doses. Some of the species or strains distributed in probiotic markets raised some safety concerns such as causing human infections or transmitting antibiotic resistance genes. Therefore continued efforts to improve strain characteristics with respect to the efficacy through evidence-based human studies and evaluation of the safety are desired.

Keywords

References

  1. Bezkorovanyl, A. Ecology of bifidobacteria. In : Bezkorovainy A, Miller-Catchpole R, editors. Biochemistry and physiology of bifidobacteria. Florida : CRC press. 1989:29-72
  2. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66:365-78 https://doi.org/10.1111/j.1365-2672.1989.tb05105.x
  3. Otte JM, Cario E, Podolsky DK. Mechanism of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004;126:1054-70 https://doi.org/10.1053/j.gastro.2004.01.007
  4. Tanaka K, Ishikawa H. Role of intestinal bacterial flora in oral tolerance induction. Histol Histopathol 2004;19:907-14
  5. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45
  6. Delneste Y, Donnet-Hughes A, Schiffrin EJ. Functional foods : mechanisms of action on immunocompetent cells. Nutr Rev 1998;56:93S-8S https://doi.org/10.1111/j.1753-4887.1998.tb01650.x
  7. Blum S, Alvarez S, Haller D, Perez P, Schiffrin EJ. Intestinal microflora and the interaction with immunocompetent cells. Antonie Van Leeuwenhoek 1999;67:199-205
  8. MacDonald TT, Pettersson S. Bacterial regulation of intestinal immune responses. Inflamm Bowel Dis 2000;6:116-22 https://doi.org/10.1002/ibd.3780060209
  9. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999;29:342-6
  10. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-20 https://doi.org/10.1067/mai.2001.118130
  11. Kalliomki M, Kirjavainen P, Eorola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107:129-34 https://doi.org/10.1067/mai.2001.111237
  12. Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tagira Y, et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2003:111:587-91 https://doi.org/10.1067/mai.2003.105
  13. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001;30:43-7 https://doi.org/10.1111/j.1574-695X.2001.tb01548.x
  14. Joint FAO/WHO Expert Consultation on 'Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria.' 2001:1-32
  15. Report of Joint FAO/WHO Working Group on 'Drafting guide lines for the evaluation of probiotics in food' 2002
  16. Natural Health Products Directorate 'Evidence for safety and efficacy of finished natural health products' 2003
  17. Notario R, Leardini N, Borda N, Gambande T, Cerutti H. Hepatic abscess and bacteremia due to Lactobacillus rhamnosus. Rev Argent Microbiol 2003;35:100-1
  18. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, et al.. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999;28:1159-60 https://doi.org/10.1086/514766
  19. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism(rhamnosus) Clin Microbiol Infect 1999;5:290-2 https://doi.org/10.1111/j.1469-0691.1999.tb00144.x
  20. Presterl E, Kneifel W, Mayer HK, Zehetgruber M, Makristathis A, Graninger W. Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion? Scand J Infect Dis 2001;33:710-4 https://doi.org/10.1080/00365540110026953
  21. Munoz P, Bouza E, Cuenca-Estrella M, Eiros HM, Perez MJ, Sanchez-Somolinos M, et al. Saccharomyces cerevisiae fungemia : an emerging infectious disease. Clin Infect Dis 2005;40:1625-34 https://doi.org/10.1086/429916
  22. Burkhardt O, Kohnlein T, Pletz M, Welte T. Saccharomyces boulardii induced sepsis : successful therapy with voriconazole after treatment failure with fluconazole. Scan J Infect Dis 2005;37:69-72 https://doi.org/10.1080/00365540510026454
  23. Coeuret V, Gueguen M, Vernoux JP. Numbers and strains of lactobacilli in some probiotic products. Int J Food Microbiol 2004;97:147-56 https://doi.org/10.1016/j.ijfoodmicro.2004.04.015
  24. Bibek Ray. Fundamental Food Microbiolgy. 2nd ed. CRC Press, 2001:211-4
  25. Sakata H, Yoshioka H, Fujita K. Development of the intestinal flora in very low birth weight infants compared to normal full-term newborns. Eur J Pediatr 1985;144:186-90 https://doi.org/10.1007/BF00451911
  26. Goldmann DA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr 1978;93:288-93 https://doi.org/10.1016/S0022-3476(78)80523-X
  27. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants : randomised controlled trial. Arch Dis Child. Fetal Neonatal Ed 1997;76:F101-7 https://doi.org/10.1136/fn.76.2.F101
  28. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4
  29. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4
  30. Dani C, Biadaioli R, Bertini G, Marteli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-8 https://doi.org/10.1159/000063096
  31. Millar MR, Bacon C, Smith SL, Walker V, Hall MA. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child 1993;69:483-7 https://doi.org/10.1136/adc.69.5_Spec_No.483
  32. Butel MJ, Waligora-Dupriet AJ, Szylit O. Oligofructose and experimental model of neonatal necrotising enterocolitis. Br J Nutr 2002;87 Suppl 2:213-9
  33. Hoyme UB, Saling E. Efficient prematurity prevention is possible by pH-self measurement and immediate therapy of threatening ascending infection. Eur J Obstet Gynecol Reprod Biol 2004;115:148-53
  34. Rio ME, Zago LB, Garcia H, Winter L. Influence of nutritional status on the effectiveness of a dietary supplement of live Lactobacillus to prevent and cure diarrhoea in children. Arch Latinoam Nutr 2004;54:287-92
  35. Weizman Z, Asli G, Alsheikh A. Effect of probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005;115:174-7
  36. Thibault H, Aubert-Jacquin C, Goulet O. Effects of long-term consumption of a fermented infant formula(with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 2004;39:147-52 https://doi.org/10.1097/00005176-200408000-00004
  37. Salazar-Lindo E, Miranda-Langschwager P, Campos-Sanchez M, Chea-Woo E, Sack RB. Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea : a randomized, double-blind, placebo controlled clinical trial. BMC Pediatr 2004;4:18 https://doi.org/10.1186/1471-2431-4-18
  38. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH. Long-term consumption of infant formulas containing live probiotic bacteria : tolerance and safety. Am J Clin Nutr 2004;79:261-7
  39. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004;(2):CD003048
  40. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol 2004;78:10213-20
  41. Conner ME and Ramig RF. Viral enteric disease In : Nathanson N, editor. Viral pathogenesis. Philadelphia : Lippincott-Raven Publishers, 1997:713-43
  42. Graham DY and Estes MK. Viral infections of the intestine. In : Gitnick G, editor. Gastroenterology. Newyork : Medical examination publishing company, 1988:566-78
  43. Rollo EE, Kumar KP, Reich NC, Cohen J, Angel J, Greenberg HB, et al. The epithelial cell response to rotavirus infection. J Immunol 1999;163:4442-52
  44. Sheth R, Anderson J, Sato T, Oh B, Hempson SJ, Rollo E, et al. Rotavirus stimulates IL-8 secretion from cultured epithelial cells. Virology 1996;221:251-9 https://doi.org/10.1006/viro.1996.0374
  45. Ebert E. Human intestinal intraepithelial lymphocytes have potent chemotatic activity. Gastroenterology 1995;109:1154-9 https://doi.org/10.1016/0016-5085(95)90573-1
  46. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004;28:405-40 https://doi.org/10.1016/j.femsre.2004.01.003
  47. Gorbach SL. Probiotics in the third millennium. Dig Liver Dis 2002;34 Suppl 2:2-7
  48. Qiao H, Duffy LC, Griffiths E, Dryja D, Leavens A, Rossman J. Immune responses in rhesus rotavirus-challenged BALB/c mice treated with bifidobacteria and prebiotic supplements. Pediatr Res 2002;51:750-5 https://doi.org/10.1203/00006450-200206000-00015
  49. Shu Q, Qu F, Gill HS. Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr 2001;33:171-7 https://doi.org/10.1097/00005176-200108000-00014
  50. Phuapradit P, Varavithya W, Vathanophas K, Sangchai R, Podhipak A, Suthutvoravut U, et al. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai 1999;82 Suppl 1:43-8
  51. Yasui H, Shida K, Matsuzaki T, Yokokura T. Immunomodulatory function of lactic acid bacteria. Antonie Van Leeuwenhoek 1999;76:383-9 https://doi.org/10.1023/A:1002041616085
  52. Sampson H, Mendelson AL, Rosen JP. Fatal and near fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;372:380-4
  53. Ogura Y, Ogura H, Zusi N. The incidence of food allergy in atopic dermatitis. Arerugi 2001;50:621-8
  54. Lee SI, Shin MH, Lee HB, Lee JS, Son BK, Koh YY, et al. Prevalences of symptoms of asthma and other allergic diseases in Korean children : a nationwide questionnaire survey. J Korean Med Sci 2001;16:155-64
  55. Karmas W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Community Health 2002;56:209-17 https://doi.org/10.1136/jech.56.3.209
  56. Kjellman B, Petterson R, Hyensjo B. Allergy among school children in a Swedish country. Allergy 1982;37 Suppl 1:5-6
  57. Williams H, Robertson C, Stewart A, Ait- Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999;103:125-38 https://doi.org/10.1016/S0091-6749(99)70536-1
  58. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the hygiene hypothesis : too clean to be true. British J Dermatol 2005;152:202-16 https://doi.org/10.1111/j.1365-2133.2004.06436.x
  59. Braun-Fahrlander CH, Riedler J, Herz U, Eder W, Waser M, Grize L, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;109:379-92
  60. Hansen G, McIntire JJ, Yeung VP, Berry G, Thorbecke G.J, Chen L, et al. CD4(＋) T helper cells engineered to produce latent TGF-beta 1 reverse allergen induced airway hyper reactivity and inflammation. J Clin Invest 2000;105:61-70 https://doi.org/10.1172/JCI7589
  61. Prescott SL. Allergy : the price we pay for cleaner living? Ann Allergy Asthama Immunol 2003;90:64-70 https://doi.org/10.1016/S1081-1206(10)61663-8
  62. Perez-Machado MA, Ashwood P, Thompson MA, Latcham F, Sim R, Walker-Smith JA, et al. Reduced transforming growth factorbeta 1-producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 2003:30:2307-15
  63. Bongaerts GPA, Severijnen RSVM. Preventive and curative effects of probiotics in atopic patients. Medical Hypotheses 2005;64:1089-92 https://doi.org/10.1016/j.mehy.2004.10.018
  64. Teitelbaum JE, Walker WA. Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu Rev Nut 2002;22:107-38 https://doi.org/10.1146/annurev.nutr.22.110901.145412
  65. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999;353:1485-8 https://doi.org/10.1016/S0140-6736(98)09344-1
  66. Hattori K, Yamamoto A, Sasai M, Taniuchi S, Kojima T, Kobayashi Y, et al. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi 2003;52:20-30
  67. Isolauri E, Arvola T, Stas Y, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1605-10 https://doi.org/10.1046/j.1365-2222.2000.00943.x
  68. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111:389-95 https://doi.org/10.1067/mai.2003.389
  69. Majamaa H, Isolauri E. Probiotics : a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-85 https://doi.org/10.1016/S0091-6749(97)70093-9
  70. Van de Water J, Keen CL, and Gershwin ME. The influence of chronic yogurt consumption on immunity. J Nutr 1999;129 Suppl 7:1492-5
  71. Mastrandrea F, Conrdduzza G, Serio G, Minardi A, Manelli M, Ardito S, et al. Probiotics reduce the CD34＋ hemopoietic precursor cell increased traffic in allergic subjects. Allerg Immunol (Paris) 2004;36:118-2
  72. Kallomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease : a randomized placebo-controlled trial. Lancet 2001;357:1076-9 https://doi.org/10.1016/S0140-6736(00)04259-8
  73. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004;145:612-6 https://doi.org/10.1016/j.jpeds.2004.06.068
  74. Rautava S, Kalliomki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002;109:119-21 https://doi.org/10.1067/mai.2002.120273
  75. Shashidhar H, Integlia MJ, Grand RJ. Clinical manifestions of pediatric inflammatory bowel disease. In : Kirsner JB editor. Inflamatory bowel disease. Philadelphia : W.B. Saunders Company 2000:326-34
  76. Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J Paediatr Child Health 2004;40:681-4 https://doi.org/10.1111/j.1440-1754.2004.00510.x
  77. Bruzzese E, Raia V, Gaudiello G, Polito G, Buccigrossi V, Formicola V, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004;20:813-9 https://doi.org/10.1111/j.1365-2036.2004.02174.x
  78. Ouwehand AC, Salminen S, Isolauri E. Probiotics : an overview of beneficial effects. Antonie van Leeuwenhoek 2002;82:279-89 https://doi.org/10.1023/A:1020620607611
  79. Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, et al. Increased mucosal tumour necrosis factor ${\alpha}$ production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002;51:659-64 https://doi.org/10.1136/gut.51.5.659
  80. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352-5 https://doi.org/10.1126/science.289.5483.1352
  81. Shultz M, Timmer A, Herfarth HH, Sartor RB, Vanderhoof JA, Rath HC. Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol 2004;4:5 https://doi.org/10.1186/1471-230X-4-5
  82. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease : a randomized controlled trial with Lactobacillus GG. Gut 2002;51:405-9 https://doi.org/10.1136/gut.51.3.405
  83. Furrie E, Macfarlane S, Knnedy A, Cummings JH, Walsh SV, O'neil DA, et al. Synbiotic therapy(Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis : a randomized controlled pilot trial. Gut 2005;54:242-9 https://doi.org/10.1136/gut.2004.044834
  84. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T : Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003;22:56-63
  85. Bibioloni R, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, et al. $VSL{\sharp}3$ probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005;100:1539-46 https://doi.org/10.1111/j.1572-0241.2005.41794.x
  86. Gionchetti P, Amadini C, Rizzello F, Venturi A, Palmonari V,Morselli C, et al. Probiotics - role in inflammatory bowel disease. Dig Liver Dis 2002;34 Suppl 2:58-62
  87. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, et al. Prophylaxis of pouchitis onset with probiotic therapy : a double-blind, placebo-controlled trial. Gastroenterology 2003;124:1202-9
  88. Lammers KM, Vergopoulos A, Babel N, Gionchetti P, Rizzello F, Morselli C, et al. Probiotic therapy in the prevention of pouchitis onset : decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis 2005;11:447-54
  89. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005;21:44-50
  90. Laake KO, Bjorneklett A, Aamodt G, Aabakken L, Jacobsen M, Bakka A, et al. Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouchanal-anastomosis in ulcerative colitis. Scand J Gastroenterol 2005;40:43-51 https://doi.org/10.1080/00365520410009339
  91. Kuisma J, Mentula S, Jarvinen H, Kahri A, Saxelin M, Farkkila M. Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 2003;17:509-15
  92. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33 https://doi.org/10.1038/nri1132
  93. Elson CO. Experimental models of intestinal inflammation. New insights into mechanisms of mucosal homeostasis. In : Orga PL, Mestecky J, Lamm M, Strober W, Bieneustock, McGhee J, editors. Handbook of mucosal immunology. San Diego : Academic Press, 1999;1007-24
  94. Claudio F. Inflammatory bowel disease : etiology and pathogenesis. Gastroenterology 1998;115:182-205 https://doi.org/10.1016/S0016-5085(98)70381-6
  95. Sartor RB. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In : Kirsner JB, Shorter RG, editors. Inflamatory bowel disease. Baltimore : Williams & Wilkins, 1995:96-104
  96. Linskens RK, Huijsdens XW, Savelkoul P, Vandenbroucke-Grauls CM, Meuwissen SG. The bacterial flora in inflammatory bowel disease : current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol 2001;36 Suppl 234:29-40
  97. Bamias G, Marini M, Moskaluk CA, Odashima M, Ross WG, Rivera-Nieves J, et al. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease. J Immunol 2002;169:5308-14
  98. Podolsky DK. The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2002;16:933-43 https://doi.org/10.1053/bega.2002.0354
  99. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology. 1999;116:301-9 https://doi.org/10.1016/S0016-5085(99)70126-5
  100. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41 https://doi.org/10.1016/j.cell.2004.07.002
  101. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303:1662-5 https://doi.org/10.1126/science.1091334
  102. Christensen HR, Frokiar H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002;168:171-8
  103. Drakes M, Blanchard T and Czinn S. Bacterial probiotic modulation of dendritic cells. Infect Immun 2004;72:3299-309 https://doi.org/10.1128/IAI.72.6.3299-3309.2004
  104. Seidelin JB. Colonic epithelial cell turnover : possible implications for uncreative colitis and cancer initiation. Scand J Gastoenterol 2004;3:201-11
  105. Cario E, Brown D, McKee M, Lynch- Devaney K, Gerken G, Podolsky DK. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Gastroenterol 2002;160:165-73
  106. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, et al. Toll-like receptor 9 signalling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004;126:520-8 https://doi.org/10.1053/j.gastro.2003.11.019
  107. Beg AA. ComPPARtmentalizing $NF-{\kappa}B$ in the gut. Nat Immunol 2004;5:14-16 https://doi.org/10.1038/ni0104-14
  108. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004;5:104-12 https://doi.org/10.1038/ni1018
  109. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al. Disparate CD4＋ lamina propria(LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-70
  110. Toms C, Powrie F. Control of intestinal inflammation by regulatory T cells. Microbes Infect 2001;3:929-35 https://doi.org/10.1016/S1286-4579(01)01454-X
  111. Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004;53:821-8 https://doi.org/10.1136/gut.2003.026252
  112. Marsumoto S, Watanabe N, Imaoka A, Ohabe Y. Preventive effects of Bifidobacterium- and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice. Digestion 2001;64:92-9 https://doi.org/10.1159/000048846
  113. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975-80 https://doi.org/10.1136/gut.52.7.975
  114. Ikeda Y, Akbar F, Matsui H, Onji M. Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2001;13:841-50 https://doi.org/10.1097/00042737-200107000-00013
  115. Malmstrom V, Shipton D, Singh B, Al-Shamkhani A, Puklavec MJ, Barclay AN, et al. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J Immunol 2001;166:6972-81
  116. Stagg AJ, Hart AL, Knight SC, Kamm MA. The dendritic cell : its role in intestinal inflammation and relationship with gut bacteria. Gut 2003;52:1522-9 https://doi.org/10.1136/gut.52.10.1522
  117. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005;6:507-14 https://doi.org/10.1038/ni1192
  118. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G., Bonasio R, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361-7 https://doi.org/10.1038/86373
  119. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000;191:435-43 https://doi.org/10.1084/jem.191.3.435